Metraipolis › archive › dc_602f8f565a93

Fracture Risk Associated With Dimethyl Fumarate Treatment in Multiple Sclerosis Patients: Population Heterogeneity and Temporal Patterns — Europe PMC PMID:40936323

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40936323
DOI
10.1111/cns.70612
License (as archived)
solo-consultazione
Archived
2026-10-08T14:29:58.797Z
SHA-256 of the archived text
715a0c009b7384752948bf1acc899fa9b1844bff15e5a57cc17230dcb5b7a1ae
Stable URL of this page
https://metraipolis.com/documento/dc_602f8f565a93

How to cite

Fracture Risk Associated With Dimethyl Fumarate Treatment in Multiple Sclerosis Patients: Population Heterogeneity and Temporal Patterns — Europe PMC PMID:40936323 — Europe PMC (en), https://europepmc.org/article/MED/40936323 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_602f8f565a93 (Metraipolis archive dc_602f8f565a93, sha256 715a0c009b7384752948bf1acc899fa9b1844bff15e5a57cc17230dcb5b7a1ae)
BibTeX
@misc{dc602f8f565a93,
  title = {Fracture Risk Associated With Dimethyl Fumarate Treatment in Multiple Sclerosis Patients: Population Heterogeneity and Temporal Patterns — Europe PMC PMID:40936323},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40936323},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_602f8f565a93; sha256 715a0c009b7384752948bf1acc899fa9b1844bff15e5a57cc17230dcb5b7a1ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936323. Agents can read the archived copy with the MCP tool read_document.